A GLOBAL PERSPECTIVE ON METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: FROM MOLECULAR MECHANISMS TO THERAPEUTIC STRATEGY INNOVATION